| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 182 | 2022 |
| Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B LA van Kleef, HSJ Choi, WP Brouwer, BE Hansen, K Patel, RA de Man, ... Jhep Reports 3 (5), 100350, 2021 | 82 | 2021 |
| Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: focusing on the non‐overlap groups I Ayada, LA van Kleef, LJM Alferink, P Li, RJ de Knegt, Q Pan Liver International 42 (2), 277-287, 2022 | 76 | 2022 |
| Metabolic dysfunction–associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study LA van Kleef, I Ayada, LJM Alferink, Q Pan, RJ de Knegt Hepatology 75 (2), 419-429, 2022 | 76 | 2022 |
| A global research priority agenda to advance public health responses to fatty liver disease JV Lazarus, HE Mark, AM Allen, JP Arab, P Carrieri, M Noureddin, ... Journal of hepatology 79 (3), 618-634, 2023 | 48 | 2023 |
| Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study M Serra-Burriel, A Juanola, F Serra-Burriel, M Thiele, I Graupera, E Pose, ... The Lancet 402 (10406), 988-996, 2023 | 43 | 2023 |
| Liver stiffness not fatty liver disease is associated with atrial fibrillation: the Rotterdam study LA van Kleef, Z Lu, MA Ikram, NMS de Groot, M Kavousi, RJ de Knegt Journal of Hepatology 77 (4), 931-938, 2022 | 38 | 2022 |
| Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality LA van Kleef, RJ de Knegt, WP Brouwer Hepatology 77 (3), 942-948, 2023 | 33 | 2023 |
| Association of nonalcoholic fatty liver disease and fibrosis with incident dementia and cognition: the Rotterdam study T Xiao, LA van Kleef, MK Ikram, RJ de Knegt, MA Ikram Neurology 99 (6), e565-e573, 2022 | 30 | 2022 |
| Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study I Ayada, LA van Kleef, H Zhang, K Liu, P Li, YJ Abozaid, M Lavrijsen, ... EBioMedicine 87, 2023 | 25 | 2023 |
| Objectively measured physical activity is inversely associated with nonalcoholic fatty liver disease: the Rotterdam study LA Van Kleef, A Hofman, T Voortman, RJ De Knegt Official journal of the American College of Gastroenterology| ACG 117 (2 …, 2022 | 25 | 2022 |
| Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study LA van Kleef, MJ Sonneveld, M Kavousi, MA Ikram, RA de Man, ... Hepatology 77 (2), 585-593, 2023 | 17 | 2023 |
| Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease–implications for the clinical utility of the EASL NIT guideline LA van Kleef, MJ Sonneveld, RA de Man, RJ de Knegt Journal of Hepatology 76 (1), 245-246, 2022 | 16 | 2022 |
| LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries I Graupera, M Thiele, AT Ma, M Serra-Burriel, J Pich, N Fabrellas, ... BMC public health 22 (1), 1385, 2022 | 15 | 2022 |
| Plasma proteomic signature of fatty liver disease: The Rotterdam Study YJ Abozaid, I Ayada, LA van Kleef, CL Vallerga, Q Pan, WP Brouwer, ... Hepatology 78 (1), 284-294, 2023 | 11 | 2023 |
| The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population LA van Kleef, RJ de Knegt, I Ayada, Q Pan, WP Brouwer Hepatology Communications 7 (4), e0075, 2023 | 9 | 2023 |
| The transition from NAFLD to MAFLD: One size still does not fit all—Time for a tailored approach? LA van Kleef, RJ de Knegt Hepatology 76 (5), 1243-1245, 2022 | 9 | 2022 |
| Association between the presence of metabolic comorbidities and liver-related events in patients with chronic hepatitis B LA Patmore, WK Katwaroe, D van der Spek, HSJ Choi, K Patel, ... Clinical Gastroenterology and Hepatology 21 (12), 3089-3096. e1, 2023 | 7 | 2023 |
| The new international nomenclature for steatotic liver disease: One step forward towards enhanced awareness for healthier life KJ van Erpecum, LA van Kleef, U Beuers, RJ de Knegt European Journal of Internal Medicine 117, 1-2, 2023 | 6 | 2023 |
| Liver stiffness is associated with excess mortality in the general population driven by heart failure: The Rotterdam Study LA van Kleef, MJ Sonneveld, F Zhu, MA Ikram, M Kavousi, RJ de Knegt Liver International 43 (5), 1000-1007, 2023 | 6 | 2023 |
